About
Care and conscience are
the core of our corporate values
more
the core of our corporate values
28 May,2025
2024 Environmental, Social and Governance Report
more
27 May,2025
ZYLOX Unicorn™ Vascular Closure Device Receives Regulatory Approval in Indonesia
Zylox-Tonbridge Medical Technology Co., Ltd. (“Zylox-Tonbridge” or the “Company”) today announced that its proprietary ZYLOX Unicorn™ Vascular Closure Device (VCD) has received regulatory approva...
more
04 Dec,2024
Zylox-Tonbridge 2024 Investor Open Day Successfully Held in Hangzhou
On November 28, Zylox-Tonbridge ("2190.HK", hereinafter referred to as "the Company") successfully hosted its 2024 Investor Open Day in Hangzhou, China. The event attracted more th...
more
26 Aug,2024
Zylox-Tonbridge Reports Strong Interim Financial Results for 2024, Achieving Significant Growth and Profitability
HANGZHOU, CHINA, August 20, 2024 – Zylox-Tonbridge Medical Technology Co., Ltd. (2190.HK), a leading player in China’s peripheral and neurovascular intervention markets, today announced its interim ...
more
22 Mar,2024
Zylox-Tonbridge Announces Annual Financial Results for 2023, Demonstrating Robust Growth and Improved Profitability
HANGZHOU, CHINA, March 21, 2024 – Zylox-Tonbridge Medical Technology Co., Ltd. (2190. HK), a leading medical device company in the peripheral and neurovascular interventional market in China, announc...
more
08 Mar,2024
Zylox-Tonbridge and Avinger Forge Strategic Partnership to Expand Disruptive OCT Solutions for Peripheral Vascular Interventions
HANGZHOU, CHINA, MAR 7th, 2024 – Zylox-Tonbridge (2190.HK, "the Company"), a leading medical device company in the peripheral and neurovascular interventional market in China, today announc...
more
